ASPE Conversion Disclosure
Orbimed Advisors Llc · SEC Form 4 · Filed Nov 4, 2026
Conversion
Calculated transaction value
$0
Orbimed Advisors Llc Director / Ten Percent Owner
ASPE
Transaction date
Nov 2, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 2 days later
ASPE daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series Seed-2 Convertible Preferred Stock on Common Stock
- Quantity / price
- 196,541 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0000947871-26-000980
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$15M
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | Not reported |
| Aspen Neuroscience, Inc. ASPE | Buy | Nov 2, 2026 | $15M |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | Not reported |
| Aspen Neuroscience, Inc. ASPE Current | Conversion | Nov 2, 2026 | $0 |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | Not reported |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | $0 |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | $0 |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | Not reported |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | $0 |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | Not reported |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | $0 |